(Q54538229)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22222637%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Accuracy of HER2 status determination on breast core-needle biopsies (immunohistochemistry, FISH, CISH and SISH vs FISH) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22222637%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

0 references

1 reference

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22222637%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Laurent Arnould

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22222637%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Gaëtan Macgrogan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22222637%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Marie-Pierre Chenard

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22222637%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

André Balaton

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22222637%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Sophie Beauclair

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22222637%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Frederique Penault-Llorca

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22222637%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

6 January 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22222637%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22222637%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22222637%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22222637%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

675-682

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22222637%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/modpathol.2011.201

19 January 2020

exact match

0 references

cites work

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.201

Best Practice No 176: Updated recommendations for HER2 testing in the UK

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.201

[Update of the GEFPICS' recommendations for HER2 status determination in breast cancers in France].

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.201

Updated recommendations from the Canadian National Consensus Meeting on HER2/neu testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.201

Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.201

Real-world performance of HER2 testing--National Surgical Adjuvant Breast and Bowel Project experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.201

Silver in situ hybridization (SISH) for determination of HER2 gene status in breast carcinoma: comparison with FISH and assessment of interobserver reproducibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.201

Comparison of automated silver enhanced in situ hybridisation (SISH) and fluorescence ISH (FISH) for the validation of HER2 gene status in breast carcinoma according to the guidelines of the American Society of Clinical Oncology and the College of A

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.201

Real time RT-PCR approach for the evaluation of ERBB2 overexpression in breast cancer archival samples: a comparative study with FISH, SISH, and immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.201

Evaluation of automated silver-enhanced in situ hybridization (SISH) for detection of HER2 gene amplification in breast carcinoma excision and core biopsy specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.201

HER2 testing on core needle biopsy specimens from primary breast cancers: interobserver reproducibility and concordance with surgically resected specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.201

Accurately assessing her-2/neu status in needle core biopsies of breast cancer patients in the era of neoadjuvant therapy: emerging questions and considerations addressed

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.201

Comparison of fluorescent in situ hybridization HER-2/neu results on core needle biopsy and excisional biopsy in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.201

The accuracy of preoperative core biopsy in determining histologic grade, hormone receptors, and human epidermal growth factor receptor 2 status in invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.201

Preoperative profiling of symptomatic breast cancer by diagnostic core biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.201

Do the histologic features and results of breast cancer biomarker studies differ between core biopsy and surgical excision specimens?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.201

Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.201

Comparison of core needle biopsy (CNB) and surgical specimens for accurate preoperative evaluation of ER, PgR and HER2 status of breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.201

Prognostic markers in breast cancer: the reliability of HER2/neu status in core needle biopsy of 325 patients with primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.201

Breast core needle biopsy: issues and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.201

Patterns of her-2/neu amplification and overexpression in primary and metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.201

7 January 2021

Calibration of immunohistochemistry for assessment of HER2 in breast cancer: results of the French multicentre GEFPICS study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.201

7 January 2021

Re: HER2 Testing in the Real World

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.201

7 January 2021

Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.201

7 January 2021

Clinical importance of HER2 immunohistologic heterogeneous expression in core-needle biopsies vs resection specimens for equivocal (immunohistochemical score 2+) cases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.201

7 January 2021

Reliability of prognostic factors in breast carcinoma determined by core needle biopsy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.201

7 January 2021

Reliability of human epidermal growth factor receptor 2 immunohistochemistry in breast core needle biopsies

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.201

7 January 2021

Gastrosplenic fistula from Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.201

7 January 2021